Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 15 de 15
Filtrer
Plus de filtres











Base de données
Gamme d'année
2.
Brain Res ; 1663: 78-86, 2017 05 15.
Article de Anglais | MEDLINE | ID: mdl-28288867

RÉSUMÉ

Moderate traumatic brain injury (TBI) might increase the vulnerability to neuronal neurodegeneration, but the basis of such selective neuronal susceptibility has remained elusive. In keeping with the disruption of the blood-brain barrier (BBB) caused by TBI, changes in BBB permeability following brain injury could facilitate the access of xenobiotics into the brain. To test this hypothesis, here we evaluated whether TBI would increase the susceptibility of nigrostriatal dopaminergic fibers to the systemic administration of 6-hydroxydopamine (6-OHDA), a classic neurotoxin used to trigger a PD-like phenotype in mice, but that in normal conditions is unable to cross the BBB. Adult Swiss mice were submitted to a moderate TBI using a free weight-drop device and, 5h later, they were injected intraperitoneally with a single dose of 6-OHDA (100mg/kg). Afterwards, during a period of 4weeks, the mice were submitted to a battery of behavioral tests, including the neurological severity score (NSS), the open field and the rotarod. Animals from the TBI plus 6-OHDA group displayed significant motor and neurological impairments that were improved by acute l-DOPA administration (25mg/kg, i.p.). Moreover, the observation of the motor deficits correlates with (i) a significant decrease in the tyrosine hydroxylase levels mainly in the rostral striatum and (ii) a significant increase in the levels of striatal glial fibrillary acidic protein (GFAP) levels. On the whole, the present findings demonstrate that a previous moderate TBI event increases the susceptibility to motor, neurological and neurochemical alterations induced by systemic administration of the dopaminergic neurotoxin 6-OHDA in mice.


Sujet(s)
Lésions traumatiques de l'encéphale/métabolisme , Oxidopamine/toxicité , Animaux , Comportement animal , Barrière hémato-encéphalique/métabolisme , Encéphale/métabolisme , Lésions encéphaliques/métabolisme , Lésions traumatiques de l'encéphale/complications , Lésions traumatiques de l'encéphale/anatomopathologie , Corps strié/métabolisme , Modèles animaux de maladie humaine , Dopamine/métabolisme , Neurones dopaminergiques/effets des médicaments et des substances chimiques , Protéine gliofibrillaire acide/métabolisme , Lévodopa/métabolisme , Souris , Maladies neurodégénératives , Syndromes neurotoxiques/métabolisme , Oxidopamine/métabolisme , Tyrosine 3-monooxygenase/métabolisme
4.
Mol Neurobiol ; 53(6): 3891-3899, 2016 08.
Article de Anglais | MEDLINE | ID: mdl-26164273

RÉSUMÉ

The dorsolateral striatum (DLS) processes motor and non-motor functions and undergoes extensive dopaminergic degeneration in Parkinson's disease (PD). The nigrostriatal dopaminergic degeneration also affects other brain areas including the pre-frontal cortex (PFC), which has been associated with the appearance of anhedonia and depression at pre-motor phases of PD. Using behavioral, neurochemical, and electrophysiological approaches, we investigated the temporal dissociation between the role of the DLS and PFC in the appearance of anhedonia and defense behaviors relevant to depression in rats submitted to bilateral DLS lesions with 6-hydroxydopamine (6-OHDA; 10 µg/hemisphere). 6-OHDA induced partial dopaminergic nigrostriatal damage with no gross motor impairments. Anhedonic-like behaviors were observed in the splash and sucrose consumption tests only 7 days after 6-OHDA lesion. By contrast, defense behaviors relevant to depression evaluated in the forced swimming test and social withdrawal only emerged 21 days after 6-OHDA lesion when anhedonia was no longer present. These temporally dissociated behavioral alterations were coupled to temporal- and structure-dependent alterations in dopaminergic markers such as dopamine D1 and D2 receptors and dopamine transporter, leading to altered dopamine sensitivity in DLS and PFC circuits, evaluated electrophysiologically. These results provide the first demonstration of a dissociated involvement of the DLS and PFC in anhedonic-like and defense behaviors relevant to depression in 6-OHDA-lesioned rats, which was linked with temporal fluctuations in dopaminergic receptor density, leading to altered dopaminergic system sensitivity in these two brain structures. This sheds new light to the duality between depressive and anhedonic symptoms in PD.


Sujet(s)
Anhédonie , Comportement animal , Corps strié/anatomopathologie , Dépression/induit chimiquement , Dépression/anatomopathologie , Cortex préfrontal/anatomopathologie , Animaux , Corps strié/métabolisme , Corps strié/physiopathologie , Dépression/physiopathologie , Transporteurs de la dopamine/métabolisme , Neurones dopaminergiques/métabolisme , Neurones dopaminergiques/anatomopathologie , Mâle , Activité motrice , Oxidopamine , Cortex préfrontal/métabolisme , Cortex préfrontal/physiopathologie , Rat Wistar , Récepteurs dopaminergiques/métabolisme , Facteurs temps , Tyrosine 3-monooxygenase/métabolisme
5.
Behav Brain Res ; 301: 43-54, 2016 Mar 15.
Article de Anglais | MEDLINE | ID: mdl-26707254

RÉSUMÉ

Parkinson's disease (PD) is characterized by motor dysfunction associated with dopaminergic degeneration in the dorsolateral striatum (DLS). However, motor symptoms in PD are often preceded by short-term memory deficits, which have been argued to involve deregulation of medial prefrontal cortex (mPFC). We now used a 6-hydroxydopamine (6-OHDA) rat PD model to explore if alterations of synaptic plasticity in DLS and mPFC underlie short-term memory impairments in PD prodrome. The bilateral injection of 6-OHDA (20µg/hemisphere) in the DLS caused a marked loss of dopaminergic neurons in the substantia nigra (>80%) and decreased monoamine levels in the striatum and PFC, accompanied by motor deficits evaluated after 21 days in the open field and accelerated rotarod. A lower dose of 6-OHDA (10µg/hemisphere) only induced a partial degeneration (about 60%) of dopaminergic neurons in the substantia nigra with no gross motor impairments, thus mimicking an early premotor stage of PD. Notably, 6-OHDA (10µg)-lesioned rats displayed decreased monoamine levels in the PFC as well as short-term memory deficits evaluated in the novel object discrimination and in the modified Y-maze tasks; this was accompanied by a selective decrease in the amplitude of long-term potentiation in the mPFC, but not in DLS, without changes of synaptic transmission in either brain regions. These results indicate that the short-term memory dysfunction predating the motor alterations in the 6-OHDA model of PD is associated with selective changes of information processing in PFC circuits, typified by persistent changes of synaptic plasticity.


Sujet(s)
Potentialisation à long terme/physiologie , Troubles de la mémoire/physiopathologie , Mémoire à court terme/physiologie , Syndromes parkinsoniens/physiopathologie , Cortex préfrontal/physiopathologie , Animaux , 4252/physiologie , Méthode en double aveugle , Mâle , Apprentissage du labyrinthe/physiologie , Troubles de la mémoire/anatomopathologie , Activité motrice , Oxidopamine , Syndromes parkinsoniens/anatomopathologie , Syndromes parkinsoniens/psychologie , Cortex préfrontal/anatomopathologie , Rat Wistar , Test du rotarod , Mémoire spatiale/physiologie , Transmission synaptique/physiologie , Techniques de culture de tissus
6.
J Ethnopharmacol ; 143(1): 158-69, 2012 Aug 30.
Article de Anglais | MEDLINE | ID: mdl-22721880

RÉSUMÉ

ETHNOPHARMACOLOGICAL RELEVANCE: Rosemary, Rosmarinus officinalis L., has several therapeutic applications in folk medicine for the treatment of a wide range of diseases, including depression. AIM OF THE STUDY: To evaluate the ability of Rosmarinus officinalis hydroalcoholic extract (ROHE), as compared to the positive control fluoxetine, to reverse behavioral (hyperactivity, anhedonic behavior and learning deficit in water maze) and biochemical alterations (serum glucose level and acetylcholinesterase, AChE, activity) induced by an animal model of depression, the olfactory bulbectomy (OB) in mice. MATERIALS AND METHODS: Locomotor and exploratory behavior was assessed in the open-field, novel object and novel cage tests, anhedonic behavior was assessed in the splash test; cognitive deficits were evaluated in the water maze task. For the first set of experiments, ROHE (10-300 mg/kg) or fluoxetine (10mg/kg) was administered once daily (p.o.) for 14 days after OB and the behavioral tests were performed. For the second set of experiments, serum glucose and hippocampal and cerebrocortical AChE activity were determined in OB and SHAM-operated mice treated orally with ROHE (10mg/kg), fluoxetine (10mg/kg) or vehicle. RESULTS: ROHE (10-300 mg/kg), similar to fluoxetine, reversed OB-induced hyperactivity, increased exploratory and anhedonic behavior. OB needed significantly more trials in the training session to acquire the spatial information, but they displayed a similar profile to that of SHAM mice in the test session (24h later), demonstrating a selective deficit in spatial learning, which was not reversed by ROHE or fluoxetine. A reduced serum glucose level and an increased hippocampal AChE activity were observed in bulbectomized mice; only the latter effect was reversed by fluoxetine, while both effects were reversed by ROHE. CONCLUSIONS: ROHE exerted an antidepressant-like effect in bulbectomized mice and was able to abolish AchE alterations and hypoglycemia, but not spatial learning deficit induced by OB. Overall, results suggest the potential of Rosmarinus officinalis for the treatment of depression, validating the traditional use of this plant.


Sujet(s)
Comportement animal/effets des médicaments et des substances chimiques , Dépression/traitement médicamenteux , Incapacités d'apprentissage/métabolisme , Apprentissage/effets des médicaments et des substances chimiques , Phytothérapie , Extraits de plantes/usage thérapeutique , Rosmarinus , Acetylcholinesterase/métabolisme , Animaux , Antidépresseurs/pharmacologie , Antidépresseurs/usage thérapeutique , Glycémie/métabolisme , Dépression/complications , Dépression/métabolisme , Comportement d'exploration/effets des médicaments et des substances chimiques , Femelle , Fluoxétine/pharmacologie , Fluoxétine/usage thérapeutique , Hippocampe/effets des médicaments et des substances chimiques , Hippocampe/métabolisme , Hypercinésie/traitement médicamenteux , Hypercinésie/étiologie , Hypercinésie/métabolisme , Hypoglycémie/traitement médicamenteux , Incapacités d'apprentissage/traitement médicamenteux , Incapacités d'apprentissage/étiologie , Souris , Lignées consanguines de souris , Bulbe olfactif/chirurgie , Extraits de plantes/pharmacologie
7.
J Neural Transm (Vienna) ; 117(12): 1337-51, 2010 Dec.
Article de Anglais | MEDLINE | ID: mdl-20931248

RÉSUMÉ

We have recently demonstrated that rodents treated intranasally with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) suffered impairments in olfactory, cognitive and motor functions associated with time-dependent disruption of dopaminergic neurotransmission in different brain structures conceivably analogous to those observed during different stages of Parkinson's disease (PD). On the other hand, the proanthocyanidin-rich fraction (PRF) obtained from the bark of Croton celtidifolius Baill (Euphorbiaceae), a tree frequently found in the Atlantic forest in south Brazil, has been described to have several neurobiological activities including antioxidant and anti-inflammatory properties, which may be of interest in the treatment of PD. The present data indicated that the pretreatment with PRF (10 mg/kg, i.p.) during five consecutive days was able to prevent mitochondrial complex-I inhibition in the striatum and olfactory bulb, as well as a decrease of the enzyme tyrosine hydroxylase expression in the olfactory bulb and substantia nigra of rats infused with a single intranasal administration of MPTP (1 mg/nostril). Moreover, pretreatment with PRF was found to attenuate the short-term social memory deficits, depressive-like behavior and reduction of locomotor activity observed at different periods after intranasal MPTP administration in rats. Altogether, the present findings provide strong evidence that PRF from C. celtidifolius may represent a promising therapeutic tool in PD, thus being able to prevent both motor and non-motor early symptoms of PD, together with its neuroprotective potential.


Sujet(s)
Croton/composition chimique , Neuroprotecteurs/pharmacologie , Syndromes parkinsoniens/traitement médicamenteux , Extraits de plantes/pharmacologie , Proanthocyanidines/pharmacologie , Administration par voie nasale , Animaux , Modèles animaux de maladie humaine , Mâle , Neuroprotecteurs/administration et posologie , Extraits de plantes/administration et posologie , Proanthocyanidines/usage thérapeutique , Rats , Rat Wistar
8.
Exp Neurol ; 226(2): 274-84, 2010 Dec.
Article de Anglais | MEDLINE | ID: mdl-20816828

RÉSUMÉ

The accumulation of amyloid-beta (Aß) peptides in the brain of human and rodents has been associated with the activation of glial cells, neuroinflammatory and oxidative responses, and cognitive deficits. These oxidative changes leave glutamate transporters more vulnerable and may result in reduction of their functions, resulting in excitotoxic damage. Herein, we evaluated the effects of atorvastatin, a HMG-CoA reductase inhibitor, in molecular and behavioral alterations induced by a single intracerebroventricular injection of aggregated Aß(1-40) (400 pmol) in mice. An increased glial fibrillar acidic protein (GFAP) expression and cyclooxygenase-2 (COX-2) levels, as well as increased lipid peroxidation and impairment in the glutathione antioxidant system and cell degeneration was found in the hippocampus of Aß(1-40)-treated mice. Aß(1-40) also induced a marked decrease in glutamatergic transporters (GLAST and GLT-1) expression and in l-[³H] glutamate uptake in mice hippocampus, in addition to spatial learning and memory deficits. Atorvastatin (10 mg/kg/day v.o.) was administered after Aß(1-40) injection and through seven consecutive days. Atorvastatin treatment was neuroprotective against cell degeneration induced by Aß(1-40), reducing inflammatory and oxidative responses and increasing the expression of glutamatergic transporters. On the other hand, atorvastatin did not reverse the cognitive impairments and failed to alter the hippocampal glutamate uptake in Aß(1-40)-treated mice. These results reinforce and extend the notion of the potential neuroprotective action of atorvastatin against the neuronal toxicity induced by Aß(1-40). In addition, the present findings suggest that the spatial learning and memory deficits induced by Aß peptides in rodents may not be entirely related to neuronal damage.


Sujet(s)
Peptides bêta-amyloïdes/toxicité , Encéphalite , Acides heptanoïques/pharmacologie , Hippocampe/anatomopathologie , Inhibiteurs de l'hydroxyméthylglutaryl-CoA réductase/pharmacologie , Neurones/effets des médicaments et des substances chimiques , Stress oxydatif/effets des médicaments et des substances chimiques , Fragments peptidiques/toxicité , Pyrroles/pharmacologie , Système X-AG de transport d'acides aminés/métabolisme , Analyse de variance , Animaux , Animaux nouveau-nés , Astrocytes/effets des médicaments et des substances chimiques , Atorvastatine , Mort cellulaire/effets des médicaments et des substances chimiques , Cyclooxygenase 2/métabolisme , Encéphalite/induit chimiquement , Encéphalite/anatomopathologie , Encéphalite/prévention et contrôle , Fluorescéines , Régulation de l'expression des gènes/effets des médicaments et des substances chimiques , Acide glutamique/métabolisme , Glutathion/métabolisme , Glutathione peroxidase/métabolisme , Glutathione reductase/métabolisme , Humains , Techniques in vitro , Incapacités d'apprentissage/induit chimiquement , Incapacités d'apprentissage/traitement médicamenteux , Mâle , Apprentissage du labyrinthe/effets des médicaments et des substances chimiques , Troubles de la mémoire/induit chimiquement , Troubles de la mémoire/traitement médicamenteux , Souris , Protéines de tissu nerveux/métabolisme , Composés chimiques organiques , Propidium , Tritium/métabolisme
9.
J Pharm Pharmacol ; 62(8): 1061-8, 2010 Aug.
Article de Anglais | MEDLINE | ID: mdl-20663041

RÉSUMÉ

OBJECTIVES: The aim of the present study was to evaluate the possible neurobehavioural effects in rats of the proanthocyanidin-rich fraction (PRF) isolated from the bark of Croton celtidifolius (Euphorbiaceae). METHODS: Adult Wistar rats were treated with the PRF (0.3-30 mg/kg) and evaluated in different behavioural paradigms classically used for the screening of drugs with psychoactive effects. KEY FINDINGS: Acute intraperitoneal (i.p.) administration of PRF decreased spontaneous locomotor activity (open field arena and activity cage), enhanced the duration of ethyl ether-induced hypnosis, increased the latency to the first convulsion induced by pentylenetetrazole (60 mg/kg, i.p.) and attenuated apomorphine-induced (0.5 mg/kg, i.p.) stereotyped behaviour. In lower doses, PRF (0.3 or 3 mg/kg, i.p.) increased the frequency of open arm entries in the elevated plus-maze test. CONCLUSIONS: The present findings suggest that the systemic administration of PRF induces a wide spectrum of behavioural alterations in rats, consistent with the putative existence of hypnosedative, anticonvulsant and anxiolytic compounds.


Sujet(s)
Comportement animal/effets des médicaments et des substances chimiques , Agents du système nerveux central/pharmacologie , Croton , Extraits de plantes/pharmacologie , Proanthocyanidines/pharmacologie , Anesthésiques par inhalation/pharmacologie , Animaux , Anxiolytiques/pharmacologie , Anticonvulsivants/pharmacologie , Neuroleptiques/pharmacologie , Apomorphine/pharmacologie , Agents du système nerveux central/administration et posologie , Agents du système nerveux central/isolement et purification , Conscience/effets des médicaments et des substances chimiques , Croton/composition chimique , Modèles animaux de maladie humaine , Relation dose-effet des médicaments , Oxyde de diéthyle/pharmacologie , Hypnotiques et sédatifs/pharmacologie , Injections péritoneales , Mâle , Activité motrice/effets des médicaments et des substances chimiques , Pentétrazol , Écorce , Extraits de plantes/administration et posologie , Proanthocyanidines/administration et posologie , Proanthocyanidines/isolement et purification , Rats , Rat Wistar , Crises épileptiques/induit chimiquement , Crises épileptiques/prévention et contrôle , Comportement stéréotypé/effets des médicaments et des substances chimiques
10.
J Neurotrauma ; 27(10): 1883-93, 2010 Oct.
Article de Anglais | MEDLINE | ID: mdl-20649482

RÉSUMÉ

Cognitive deficits and psychiatric disorders are significant sequelae of traumatic brain injury (TBI). Animal models have been widely employed in TBI research, but few studies have addressed the effects of experimental TBI of different severities on emotional and cognitive parameters. In this study, mice were subjected to weight-drop TBI to induce mild, intermediate, or severe TBI. After neurological assessment, the mice recovered for 10 days, and were then subjected to a battery of behavioral tests, which included open-field, elevated plus-maze, forced swimming, tail suspension, and step-down inhibitory avoidance tests. Oxidative stress-related parameters (nonprotein thiols [NPSH], glutathione peroxidase [GPx], glutathione reductase [GR], and thiobarbituric acid reactive species [TBARS]) were quantified in the cortex and hippocampus at 2 and 24 h and 14 days after TBI, and histopathological analysis was performed 15 days after TBI. Mice subjected to mild TBI showed increased anxiety and depressive-like behaviors, while intermediate and severe TBI induced robust memory deficits. The severe TBI group also displayed increased locomotor activity. Intermediate and severe TBI caused extensive macroscopic and microscopic brain damage, while mild TBI typically had no histological abnormalities. Moreover, a significant increase in TBARS in the ipsilateral cortex and GPx in the ipsilateral hippocampus was observed at 24 h and 14 days, respectively, following intermediate TBI. The current experimental TBI model induced emotional and cognitive changes comparable to sequelae seen in human TBI, and it might therefore represent a useful approach to the study of mechanisms of and new treatments for TBI and related disorders.


Sujet(s)
Comportement animal/physiologie , Lésions encéphaliques/physiopathologie , Lésions encéphaliques/psychologie , Émotions/physiologie , Stress oxydatif/physiologie , Analyse de variance , Animaux , Apprentissage par évitement/physiologie , Lésions encéphaliques/métabolisme , Cortex cérébral/métabolisme , Cortex cérébral/physiopathologie , Glutathione peroxidase/métabolisme , Glutathione reductase/métabolisme , Hippocampe/métabolisme , Hippocampe/physiopathologie , Score de gravité des lésions traumatiques , Mâle , Souris , Activité motrice/physiologie , Statistique non paramétrique
11.
Ann N Y Acad Sci ; 1170: 629-36, 2009 Jul.
Article de Anglais | MEDLINE | ID: mdl-19686204

RÉSUMÉ

The presence of smell loss and the early pathological involvement of the olfactory pathways in the early stages of some neurodegenerative disorders are in accord with the tenants of the olfactory vector hypothesis. This hypothesis postulates that some such diseases may be caused or catalyzed by agents that enter the brain via the olfactory mucosa. In this study, rats infused intranasally (i.n.) with a low concentration of the proneurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) subsequently suffered olfactory, cognitive, and motor function impairments conceivably analogous to those observed during different stages of the development of Parkinson's disease (PD). Such infusion decreased the expression of the enzyme tyrosine hydroxylase in the olfactory bulb and substantia nigra by means of apoptotic mechanisms, reducing dopamine levels in different brain structures, such as the olfactory bulb, striatum, and prefrontal cortex. These findings reinforce the suggestion that the olfactory system may be a particularly sensitive route for the penetration of xenobiotic agents into the central nervous system and that the i.n. MPTP rat model may provide insight into the underlying mechanisms of PD pathogenesis, potentially leading to the development of new therapeutic strategies for this devastating disease.


Sujet(s)
1-Méthyl-4-phényl-1,2,3,6-tétrahydropyridine/administration et posologie , Modèles animaux de maladie humaine , Intoxication au MPTP/complications , Maladie de Parkinson/étiologie , Animaux , Dopamine/métabolisme , Transporteurs de la dopamine/métabolisme , Exposition par inhalation , Intoxication au MPTP/métabolisme , Maladie de Parkinson/métabolisme , Rats
12.
Brain Res Bull ; 79(3-4): 177-81, 2009 May 29.
Article de Anglais | MEDLINE | ID: mdl-19429188

RÉSUMÉ

Sexual dimorphism during mammalian neural development seems to contribute to differential gender-related incidence in malformations of cortical development in both humans and rodents. Here we investigated the existence of differential gender-related susceptibility to learning and memory deficits and brain injury severity in mice submitted to a microgyria model. Newborn male and female C57BL/6 mice (P0) were submitted to a unilateral freezing lesion (FL) using a cooled steel probe, placed over the right midline anteroposterior plane. Mice were allowed to survive for 12-14 weeks and then were submitted to behavioral tasks and brain morphological analyses. Injured mice from both genders did not present gross locomotor alterations, and the freezing lesion resulted in similar brain damage in male and female mice. Additionally, a selective disruption in the short-term social recognition memory was observed in injured male mice while the long-term inhibitory avoidance memory was not affected by both the factors. These results indicate a reduced susceptibility of female to short-term social-memory deficits induced by neonatal model of microgyria in mice, suggesting that the cognitive deficits induced by freezing lesions in rodents may not be entirely related to the severity of brain injury.


Sujet(s)
Lésions encéphaliques , Troubles de la cognition/physiopathologie , Prédisposition aux maladies , Incapacités d'apprentissage/physiopathologie , Troubles de la mémoire/physiopathologie , Caractères sexuels , Animaux , Animaux nouveau-nés , Comportement animal/physiologie , Lésions encéphaliques/complications , Lésions encéphaliques/anatomopathologie , Lésions encéphaliques/physiopathologie , Troubles de la cognition/étiologie , Femelle , Humains , Incapacités d'apprentissage/étiologie , Mâle , Troubles de la mémoire/étiologie , Souris , Souris de lignée C57BL , Activité motrice/physiologie , Grossesse , 35416 , Comportement social
13.
Pharmacol Biochem Behav ; 92(1): 32-8, 2009 Mar.
Article de Anglais | MEDLINE | ID: mdl-18992274

RÉSUMÉ

Several studies have emphasized the role of learning in the development of rapid tolerance and have shown that glutamate-mediated neurotransmission plays an important role in this phenomenon. Since the AMPA/kainate receptor system is directly involved in plasticity mechanisms, the influence of this receptor system on rapid tolerance induced by ethanol was studied using the rotarod. In the first experiment, mice were pretreated with aniracetam, an agonist of AMPA/kainate receptors, 30 min before ethanol (2.75 g/kg; IP) treatment, and tested on the rotarod. After 24 h, the groups were tested on the rotarod under ethanol treatment. Aniracetam facilitated the acquisition of rapid tolerance to ethanol. In the second experiment, mice received DNQX, a competitive antagonist of the AMPA receptor, 30 min before ethanol treatment (3 g/kg) and submitted to the rotarod. This dose of ethanol produced tolerance per se. Groups were tested under ethanol treatment (1.75 g/kg) after 24 h. DNQX blocked rapid tolerance to ethanol. Using a similar protocol, the third experiment showed that DNQX blocked the aniracetam-induced facilitation of rapid tolerance to ethanol. Our results show that aniracetam facilitates whereas DNQX blocks ethanol tolerance, suggesting that the non-NMDA receptors are involved in this phenomenon.


Sujet(s)
Dépresseurs du système nerveux central/pharmacologie , Éthanol/pharmacologie , Antagonistes des acides aminés excitateurs/pharmacologie , Nootropiques/pharmacologie , Pyrrolidones/pharmacologie , Quinoxalines/pharmacologie , Animaux , Dépresseurs du système nerveux central/sang , Tolérance aux médicaments , Éthanol/sang , Femelle , Acide glutamique/métabolisme , Souris , Équilibre postural/effets des médicaments et des substances chimiques , Performance psychomotrice/effets des médicaments et des substances chimiques , Récepteur de l'AMPA/antagonistes et inhibiteurs , Récepteurs kaïnate/antagonistes et inhibiteurs
14.
Brain Res ; 1241: 148-56, 2008 Nov 19.
Article de Anglais | MEDLINE | ID: mdl-18840415

RÉSUMÉ

The cellular prion protein (PrP(C)) has been implicated with the modulation of neuronal apoptosis, adhesion, neurite outgrowth and maintenance which are processes involved in the neocortical development. Malformations of cortical development (MCD) are frequently associated with neurological conditions including mental retardation, autism, and epilepsy. Here we investigated the behavioral performance of female adult PrP(C)-null mice (Prnp(0/0)) and their wild-type controls (Prnp(+/+)) presenting unilateral polymicrogyria, a MCD experimentally induced by neonatal freeze-lesion in the right hemisphere. Injured mice from both genotypes presented similar locomotor activity but Prnp(0/0) mice showed a tendency to increase anxiety-related responses when compared to Prnp(+/+) animals. Additionally, injured Prnp(0/0) mice have a poorer performance in the social recognition task than sham-operated and Prnp(+/+) injured ones. Moreover the step-down inhibitory avoidance task was not affected by the procedure or the genotype of the animals. These data suggest that the genetic deletion of PrP(C) confers increased susceptibility to short-term social memory deficits induced by neonatal freezing model of polymicrogyria in mice.


Sujet(s)
Troubles de la cognition/métabolisme , Troubles de la mémoire/métabolisme , Néocortex/malformations , Neurogenèse/génétique , Protéines PrPC/génétique , Animaux , Troubles anxieux/génétique , Troubles anxieux/métabolisme , Troubles anxieux/physiopathologie , Troubles de la cognition/génétique , Troubles de la cognition/physiopathologie , Basse température/effets indésirables , Dénervation , Modèles animaux de maladie humaine , Femelle , Hypoxie-ischémie du cerveau/complications , Hypoxie-ischémie du cerveau/étiologie , Hypoxie-ischémie du cerveau/physiopathologie , Troubles de la mémoire/génétique , Troubles de la mémoire/physiopathologie , Troubles mentaux/génétique , Troubles mentaux/métabolisme , Troubles mentaux/physiopathologie , Souris , Souris knockout , Néocortex/traumatismes , Néocortex/physiopathologie
15.
J Ethnopharmacol ; 120(3): 465-73, 2008 Dec 08.
Article de Anglais | MEDLINE | ID: mdl-18948179

RÉSUMÉ

AIM OF THE STUDY: Ilex paraguariensis St. Hilaire (Aquifoliaceae) is a plant widely cultivated in South America that is used to prepare a tea-like beverage with a reputation to improve cognitive function, a response that has been attributed to the constituents of the leaves, especially caffeine. Our previous study indicated that the hydroalcoholic extract of Ilex paraguariensis presents an antiparkinsonian profile in reserpine- and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine hydrochloride (MPTP)-treated rodents. MATERIALS AND METHODS: In the present study, the effects of the hydroalcoholic extract of Ilex paraguariensis on the short- and long-term learning and memory of rats were assessed with the social recognition, Morris water maze, and step-down inhibitory avoidance tasks. RESULTS: A preliminary HPLC fingerprint of the plant extract confirmed the presence of caffeine (the major compound), rutin and kaemperol, and revealed the absence of detectable concentrations of caffeic acid, quercetin and ursolic acid. Acute pre-training intraperitoneal (i.p.) or oral administration of the extract of Ilex paraguariensis improved the short-term social memory in a specific manner as well as facilitated the step-down inhibitory avoidance short-term memory evaluated 1.5h after training. Moreover, a synergistic response was observed following the co-administration of 'non-effective' doses of caffeine and Ilex paraguariensis in the social memory. In contrast, pre-training administration of hydroalcoholic extract of Ilex paraguariensis did not alter the step-down inhibitory avoidance long-term memory evaluated 24h after training, while the highest dose tested (250 mg/kg, i.p.) disrupted the animals' performance in a cued version of the Morris water maze. CONCLUSION: These results partly substantiate the traditional use of mate tea for improvement of cognition indicating that acute administration of hydroalcoholic extract of Ilex paraguariensis differentially modulates short- and long-term learning and memory in rats probably through its antagonist's action on adenosine receptors.


Sujet(s)
Ilex paraguariensis/composition chimique , Apprentissage/effets des médicaments et des substances chimiques , Mémoire/effets des médicaments et des substances chimiques , Extraits de plantes/pharmacologie , Alcools , Analyse de variance , Animaux , Boissons , Caféine/analyse , Chromatographie en phase liquide à haute performance , Cognition/effets des médicaments et des substances chimiques , Kaempférols/analyse , Mâle , Apprentissage du labyrinthe/effets des médicaments et des substances chimiques , Modèles animaux , Activité motrice/effets des médicaments et des substances chimiques , Extraits de plantes/composition chimique , Feuilles de plante/composition chimique , Rats , Rat Wistar , Rutoside/analyse , Eau
SÉLECTION CITATIONS
DÉTAIL DE RECHERCHE